Immortal time bias for active treatment of cardiac transthyretin amyloidosis with aortic stenosis. Watanabe A, Hiruma Y, Asanuma T. Eur Heart J 2025 Jul 30:ehaf539. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Watanabe A, Hiruma Y, Asanuma T. Immortal time bias for active treatment of cardiac transthyretin amyloidosis with aortic stenosis. Eur Heart J 2025 Jul 30:ehaf539. doi: 10.1093.
PMID: 40737225